AMT-151

N/A

Report date: 2023/04/19 18:00:20

Base Information

Drug NameAMT-151
Drug Alias NameAMT-151
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionFolate receptor alpha modulators
TargetsFolate receptor alpha
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsFallopian Tube Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMultitude Therapeutics Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesPuzhong Discovery Medical Technology (Shanghai) Co LtdMultitude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometrial NeoplasmsFallopian Tube Neoplasms +[12] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A